These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 21638910)

  • 1. [Three cases of Fanconi syndrome associated with valproate sodium treatment].
    Inoue T; Tanaka Y; Otani R; Itabashi H; Murakami N; Nagai T; Sakuta R
    No To Hattatsu; 2011 May; 43(3):233-7. PubMed ID: 21638910
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Secondary renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Yoshikawa H; Yamazaki S; Abe Y; Abe T
    Pediatr Nephrol; 2005 Jun; 20(6):814-7. PubMed ID: 15785938
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Fanconi syndrome caused by sodium valproate: report of three severely disabled children.
    Yoshikawa H; Watanabe T; Abe T
    Eur J Paediatr Neurol; 2002; 6(3):165-7. PubMed ID: 12363104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Outcome of renal proximal tubular dysfunction with Fanconi syndrome caused by sodium valproate.
    Yamazaki S; Watanabe T; Sato S; Yoshikawa H
    Pediatr Int; 2016 Oct; 58(10):1023-1026. PubMed ID: 26896192
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fanconi syndrome caused by antiepileptic therapy with valproic Acid.
    Knorr M; Schaper J; Harjes M; Mayatepek E; Rosenbaum T
    Epilepsia; 2004 Jul; 45(7):868-71. PubMed ID: 15230715
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fever of unknown origin as the initial manifestation of valproate-induced Fanconi syndrome.
    Nozaki F; Kumada T; Kusunoki T; Fujii T; Murayama K; Ohtake A
    Pediatr Neurol; 2014 Dec; 51(6):846-9. PubMed ID: 25439492
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fanconi syndrome caused by valproic acid.
    Endo A; Fujita Y; Fuchigami T; Takahashi S; Mugishima H
    Pediatr Neurol; 2010 Apr; 42(4):287-90. PubMed ID: 20304335
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fractures and Fanconi syndrome due to prolonged sodium valproate use.
    Dhillon N; Högler W
    Neuropediatrics; 2011 Jun; 42(3):119-21. PubMed ID: 21717384
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Hypouricemia in severely disabled children: influence of valproic acid and bed-ridden state.
    Yoshikawa H; Yamazaki S; Watanabe T; Abe T
    Brain Dev; 2003 Apr; 25(3):186-90. PubMed ID: 12689697
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Risk factors for sodium valproate-induced renal tubular dysfunction.
    Koga S; Kimata T; Yamanouchi S; Tsuji S; Yoshimura K; Araki A; Kaneko K
    Clin Exp Nephrol; 2018 Apr; 22(2):420-425. PubMed ID: 28836089
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fanconi Syndrome Secondary to Sodium Valproate Therapy: Experience and Literature Review.
    Sturla Álvarez DA; Sánchez Marcos E; de Lucas Collantes C; Cantarín Extremera V; Soto Insuga V; Aparicio López C
    Pediatr Neurol; 2022 May; 130():53-59. PubMed ID: 35364461
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sodium valproate-induced Fanconi type proximal renal tubular acidosis.
    Knights M; Thekkekkara T; Morris A; Finlay E
    BMJ Case Rep; 2016 Jan; 2016():. PubMed ID: 26823359
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sodium valproate-induced Fanconi syndrome in two severely disabled patients receiving carnitine supplementation.
    Ono H
    Clin Exp Nephrol; 2019 Jan; 23(1):148-149. PubMed ID: 29679355
    [No Abstract]   [Full Text] [Related]  

  • 14. [A severe disabled case of incomplete Fanconi syndrome after discontinuation of carnitine supplementation during valproate sodium therapy].
    Ono H
    No To Hattatsu; 2007 May; 39(3):226-7. PubMed ID: 17515139
    [No Abstract]   [Full Text] [Related]  

  • 15. Autoimmune haemolytic anaemia and renal Fanconi syndrome caused by valproate therapy.
    Watanabe T; Nakayasu K; Nagayama Y
    Eur J Pediatr; 2005 Mar; 164(3):186-7. PubMed ID: 15717181
    [No Abstract]   [Full Text] [Related]  

  • 16. Valproate-induced proximal renal tubular dysfunction: clinically relevant in the severely disabled epileptic population.
    Jaffe SL; Sanford M
    Epilepsia; 2005 Apr; 46(4):599-600. PubMed ID: 15816962
    [No Abstract]   [Full Text] [Related]  

  • 17. Tubulo-interstitial nephritis caused by sodium valproate.
    Yoshikawa H; Watanabe T; Abe T
    Brain Dev; 2002 Mar; 24(2):102-5. PubMed ID: 11891102
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Renal tubular dysfunction in epileptic children on valproic acid therapy.
    Altunbaşak S; Yildizaş D; Anarat A; Burgut HR
    Pediatr Nephrol; 2001 Mar; 16(3):256-9. PubMed ID: 11322374
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Kidney Biopsy Findings in a Patient With Valproic Acid-Associated Fanconi Syndrome.
    Singer P; Sethna CB; Castellanos-Reyes L; Yaskiv O; Bijol V
    Pediatr Dev Pathol; 2019; 22(4):370-374. PubMed ID: 30565480
    [TBL] [Abstract][Full Text] [Related]  

  • 20. N-acetyl-beta-glucosaminidase and beta-galactosidase activity in children receiving antiepileptic drugs.
    Yüksel A; Cengiz M; Seven M; Cengiz S; Cenani A
    Pediatr Neurol; 1999 Jan; 20(1):24-6. PubMed ID: 10029255
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.